|
Glenmark Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
52545.79 Cr.
|
P/BV
|
6.22
|
Book Value (Rs.)
|
299.28
|
|
52 Week High/Low (Rs.)
|
1843/1272
|
FV/ML
|
1/1
|
P/E(X)
|
50.18
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
37.10
|
Div Yield (%)
|
0.13
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 1399.21 | 36.50 | 868.45 | 1441.25 | 1382.48 |
| | | | | | |
| Net CashFlow From Operating Activities | -827.60 | -265.44 | 625.39 | 1108.65 | 1131.21 |
| Net Cash Used In Investing Activities | 2.09 | 4560.89 | -528.49 | -333.28 | -675.24 |
| Net Cash Used From Financing Activities | 787.05 | -3906.13 | -77.46 | -520.49 | -441.78 |
| Foreign Exchange Gains / Losses | 55.89 | 17.68 | 12.39 | 17.55 | 13.62 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | -191.76 | 0.67 | 0.00 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 17.44 | 215.24 | 32.50 | 272.43 | 27.82 |
| Cash And Cash Equivalents Begin of Year | 1658.27 | 1443.03 | 1410.53 | 1138.10 | 1110.28 |
| Cash And Cash Equivalents End Of Year | 1675.71 | 1658.27 | 1443.03 | 1410.53 | 1138.10 |
